Guideline Recommends Direct-acting Antivirals for HCV in People With Kidney Disease Guideline Recommends Direct-acting Antivirals for HCV in People With Kidney Disease

Patients with chronic kidney disease (CKD) should be screened for hepatitis C virus (HCV) infection, and infected individuals should be treated with direct-acting antiviral (DAA) therapy, according to the updated 2018 Kidney Disease: Improving Global Outcomes (KDIGO) clinical-practice guideline.Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Gastroenterology News Source Type: news